58 related articles for article (PubMed ID: 25168151)
1. Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives.
Dey SK; Bose D; Hazra A; Naskar S; Nandy A; Munda RN; Das S; Chatterjee N; Mondal NB; Banerjee S; Saha KD
PLoS One; 2013; 8(3):e58055. PubMed ID: 23472133
[TBL] [Abstract][Full Text] [Related]
2. In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
Wanandi SI; Limanto A; Yunita E; Syahrani RA; Louisa M; Wibowo AE; Arumsari S
PLoS One; 2020; 15(11):e0240020. PubMed ID: 33211707
[TBL] [Abstract][Full Text] [Related]
3. New (S)-verbenone-isoxazoline-1,3,4-thiadiazole hybrids: synthesis, anticancer activity and apoptosis-inducing effect.
Fawzi M; Bimoussa A; Laamari Y; Oussidi AN; Oubella A; Ketatni EM; Saadi M; Ammari LE; Morjani H; Ait Itto MY; Auhmani A
Future Med Chem; 2023 Sep; 15(17):1603-1619. PubMed ID: 37772541
[No Abstract] [Full Text] [Related]
4. Synthesis of novel phytol-derived γ-butyrolactones and evaluation of their biological activity.
Gliszczyńska A; Dancewicz K; Gabryś B; Świtalska M; Wietrzyk J; Maciejewska G
Sci Rep; 2021 Feb; 11(1):4262. PubMed ID: 33608591
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evaluation of the toxicological, antioxidant and antitumor activities promoted by the compounds 2,4-dihydroxy-benzylidene-thiosemicarbazones an in silico, in vitro and in vivo study.
Leal MMFV; Silva MFD; Marques DSC; Mendes RFV; Ximenes RM; Machado DC; Silva Júnior JJD; Rodrigues CG; Filho IJDC; Lima MDCA
An Acad Bras Cienc; 2024; 96(2):e20231247. PubMed ID: 38808881
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel purpurealidin analogs and evaluation of their effect on the cancer-relevant potassium channel KV10.1.
Moreels L; Bhat C; Voráčová M; Peigneur S; Goovaerts H; Mäki-Lohiluoma E; Zahed F; Pardo LA; Yli-Kauhaluoma J; Kiuru P; Tytgat J
PLoS One; 2017; 12(12):e0188811. PubMed ID: 29220359
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from
Merecz-Sadowska A; Isca VMS; Sitarek P; Kowalczyk T; Małecka M; Zajdel K; Zielińska-Bliźniewska H; Jęcek M; Rijo P; Zajdel R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674113
[TBL] [Abstract][Full Text] [Related]
8. Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.
Roth HS; Hergenrother PJ
Curr Med Chem; 2016; 23(3):201-41. PubMed ID: 26630918
[TBL] [Abstract][Full Text] [Related]
9. HLBT-100: a highly potent anti-cancer flavanone from
Lowe HIC; Toyang NJ; Watson CT; Ayeah KN; Bryant J
Cancer Cell Int; 2017; 17():38. PubMed ID: 28286420
[TBL] [Abstract][Full Text] [Related]
10. Novel Nitrobenzazolo[3,2-
Vélez C; Cox O; Rosado-Berrios CA; Molina D; Arroyo L; Carro S; Filikov A; Kumar V; Malhotra SV; Cordero M; Zayas B
Open J Apoptosis; 2013 Apr; 2(2):13-22. PubMed ID: 25243104
[TBL] [Abstract][Full Text] [Related]
11. Repurposing Synthetic Congeners of a Natural Product Aurone Unveils a Lead Antitumor Agent Inhibiting Folded P-Loop Conformation of MET Receptor Tyrosine Kinase.
Hassan AHE; Wang CY; Lee CJ; Jeon HR; Choi Y; Moon S; Lee CH; Kim YJ; Cho SB; Mahmoud K; El-Sayed SM; Lee SK; Lee YS
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004462
[TBL] [Abstract][Full Text] [Related]
12. The NCI-60 Human Tumor Cell Line Screen: A Catalyst for Progressive Evolution of Models for Discovery and Development of Cancer Drugs.
Workman P
Cancer Res; 2023 Oct; 83(19):3170-3173. PubMed ID: 37779429
[TBL] [Abstract][Full Text] [Related]
13.
Kumar RS; Almansour AI; Arumugam N; Mohammad F; Kumar RR
Front Chem; 2020; 8():465. PubMed ID: 32582638
[TBL] [Abstract][Full Text] [Related]
14. Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies.
Youssif BGM; Morcoss MM; Bräse S; Abdel-Aziz M; Abdel-Rahman HM; Abou El-Ella DA; Abdelhafez ESMN
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257358
[TBL] [Abstract][Full Text] [Related]
15. New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations.
Bigagli E; Luceri C; De Angioletti M; Chegaev K; D'Ambrosio M; Riganti C; Gazzano E; Saponara S; Longini M; Luceri F; Cinci L
Invest New Drugs; 2018 Dec; 36(6):985-998. PubMed ID: 29607467
[TBL] [Abstract][Full Text] [Related]
16. AS1041, a Novel Synthesized Derivative of Marine Natural Compound Aspergiolide A, Arrests Cell Cycle, Induces Apoptosis, and Inhibits ERK Activation in K562 Cells.
Yuan F; Qiao L; Chen Y; Qi X; Liu Y; Li D; Gu Q; Li J; Liu M
Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29113054
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatment.
Banerjee A; Ahmed H; Yang P; Czinn SJ; Blanchard TG
Oncotarget; 2016 Jul; 7(27):41432-41444. PubMed ID: 27166181
[TBL] [Abstract][Full Text] [Related]
18. NCI in vitro and in silico anticancer screen, cell cycle pertubation and apoptosis-inducing potential of new acylated, benzylidene and isopropylidene derivatives of andrographolide.
Wong CC; Sagineedu SR; Sumon SH; Sidik SM; Phillips R; Lajis NH; Stanslas J
Environ Toxicol Pharmacol; 2014 Sep; 38(2):489-501. PubMed ID: 25168151
[TBL] [Abstract][Full Text] [Related]
19. Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G(1) arrest and apoptosis.
Jada SR; Matthews C; Saad MS; Hamzah AS; Lajis NH; Stevens MF; Stanslas J
Br J Pharmacol; 2008 Nov; 155(5):641-54. PubMed ID: 18806812
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
